Lymphoma, Mucosa-Associated Lymphoid Tissue Clinical Trial
Official title:
Multicenter Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in Extranodal Marginal Zone B-cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT Lymphoma)
Assess the therapeutic activity and safety of the combination of Chlorambucil and Rituximab
in MALT lymphomas and determine whether the addition of Rituximab to Chlorambucil will
improve the outcome of MALT lymphoma in comparison to treatment with Chlorambucil alone.
In April 2006, a third arm of treatment was added to compare the antitumor activity and
safety of rituximab alone vs chlorambucil alone
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00210392 -
VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy
|
Phase 2 | |
| Completed |
NCT00210327 -
VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy
|
Phase 2 |